Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Scilex Raises $140 Million to Support Commercialization of Non-Opioid Topical Pain Medication System
Scilex Raises $140 Million to Support Commercialization of Non-Opioid Topical Pain Medication System
Scilex Raises $140 Million to Support Commercialization of Non-Opioid Topical Pain Medication System
Submitted by
admin
on September 10, 2018 - 9:50am
Source:
CP Wire
News Tags:
Sorrento Therapeutics
Scilex
lidocaine
Headline:
Scilex Raises $140 Million to Support Commercialization of Non-Opioid Topical Pain Medication System
snippet:
One analyst predicts peak revenue of 1.1billion in 2025
Over 1.1 million lidocaine patches sold in the US in 2017
Do Not Allow Advertisers to Use My Personal information
